Particle therapy market seen reaching $2.44 billion by 2030

The Business Research Company says the global particle therapy market is on track to grow from $1.36 billion in 2025 to $2.44 billion by 2030 as cancer rates rise and precision radiation use expands. North America led the market in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - Particle therapy is gaining traction as a more precise form of radiation treatment for cancer. - The market’s growth reflects rising cancer incidence, broader use of proton therapy, and expanding investment in advanced oncology care. - The report frames particle therapy as part of a larger shift toward precision medicine in cancer treatment.

What happened: - The Business Research Company released a new particle therapy market report covering 2026-2035. - The report estimates the market will rise from $1.36 billion in 2025 to $1.53 billion in 2026. - The report forecasts the market will reach $2.44 billion by 2030. - The report says the market is growing at a 12.1% CAGR in the early period and a 12.4% CAGR over the longer forecast period. - The report is available through the full report and a free sample.

The details: - Particle therapy uses charged particles such as protons or heavier ions to target tumors with high precision. - The treatment aims energetic ionizing particles directly at the cancer site to improve outcomes. - The approach is designed to reduce damage to surrounding healthy tissue. - The report links near-term growth to rising cancer rates, early adoption of proton therapy, more specialized oncology centers, stronger clinical evidence, and investment from academic research hospitals. - The report links longer-term growth to personalized treatment approaches, higher healthcare spending on advanced cancer care, stronger demand for precision radiation, progress in particle accelerator systems, and adoption in emerging markets. - Key trends include wider use of pencil beam scanning, more single-room particle therapy centers, greater use of carbon ion therapy, better treatment planning, and increased focus on pediatric cancer care. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics, and updated graphics and tables.

Between the lines: - The report suggests particle therapy is moving from a niche treatment toward broader clinical and commercial adoption. - The strongest growth drivers are concentrated in regions with rising cancer burdens and stronger healthcare spending. - The emphasis on pediatric cancer, single-room centers, and planning software points to efforts to make particle therapy more accessible and operationally efficient. - The market’s projected growth still depends on continued capital spending because particle therapy systems are expensive and infrastructure-heavy.

What's next: - The report expects more adoption of precision radiation technologies as cancer care systems expand. - Wider deployment of particle accelerator systems and single-room centers could shape the next phase of market growth. - More information is available from The Business Research Company.

The bottom line: - Particle therapy is projected to be a fast-growing cancer treatment market, led by precision medicine demand and rising global cancer cases.